Last reviewed · How we verify
Sotradecol (SODIUM TETRADECYL SULFATE)
Sotradecol (generic name: SODIUM TETRADECYL SULFATE) is a tetradecyl sulfate Small molecule drug developed by Elkins Sinn. It is currently FDA-approved (first approved 1946) for Venous varices.
Sotradecol (Sodium Tetradecyl Sulfate) is a small molecule drug in the tetradecyl sulfate class, originally developed by Elkins Sinn and currently owned by the same company. It was FDA-approved in 1946 for the treatment of venous varices. As an off-patent medication, Sotradecol is available as a generic product from multiple manufacturers. Key safety considerations include the potential for local irritation and allergic reactions. Sotradecol is used to reduce the appearance of varicose veins.
At a glance
| Generic name | SODIUM TETRADECYL SULFATE |
|---|---|
| Sponsor | Elkins Sinn |
| Drug class | tetradecyl sulfate |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
| First approval | 1946 |
Approved indications
- Venous varices
Common side effects
- Anaphylactic shock
- Myocardial infarction
- Cerebrovascular accident
- Fatal pulmonary embolism
- Death
- Headache
- Nausea
- Vomiting
- Urticaria
- Ulceration
- Pain
- Asthma
Key clinical trials
- Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias (PHASE4)
- Pilot RCT Evaluating a One Stop Vein Clinic (NA)
- Investigation Into the Pathophysiology and Treatment of Varicose Veins (NA)
- Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations (PHASE4)
- Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding (PHASE3)
- Low Concentrate Detergents Versus Hypertonic Glucose for the Treatment of Telangiectasia (NA)
- Laser Ablation Versus Mechanochemical Ablation Trial (PHASE4)
- Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sotradecol CI brief — competitive landscape report
- Sotradecol updates RSS · CI watch RSS
- Elkins Sinn portfolio CI
Frequently asked questions about Sotradecol
What is Sotradecol?
What is Sotradecol used for?
Who makes Sotradecol?
What is the generic name of Sotradecol?
What drug class is Sotradecol in?
When was Sotradecol approved?
What development phase is Sotradecol in?
What are the side effects of Sotradecol?
Related
- Drug class: All tetradecyl sulfate drugs
- Manufacturer: Elkins Sinn — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Venous varices
- Compare: Sotradecol vs similar drugs
- Pricing: Sotradecol cost, discount & access